Data Coordinating News Today

StackArmor, Carahsoft partner with University of Utah School of Medicine to Accelerate FISMA ATO for NEMSIS

TYSONS CORNER, Va., Dec. 15, 2023 (GLOBE NEWSWIRE) -- stackArmor, Inc., a leading provider of FedRAMP, FISMA, CMMC 2.0, NIST AI RMF and StateRAMP...

Objectives To compared the effect of early antihypertensive treatment started within 24-48 h of stroke onset versus delaying treatment until day eight on reducing dependency or death. Design Multicentre, randomised, open label trial. Setting 106 hospitals in China between 13 June 2018 and 10 July 2022. Participants 4810 patients (≥40 years) were enrolled with acute ischaemic stroke within 24-48 h of symptom onset and elevated systolic blood pressure between 140 mm Hg and <220 mm Hg. Interve...

This report describes medication for opioid use disorder during pregnancy.

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from theA National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk o...

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

$125 million research initiative aims to study senescent cells, develop treatments for age-related diseases Carnegie Mellon University’s Computational

Despite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a simple test for protein in the urine to screen for this potentially deadly disorder, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.